"At Summit Cancer Centers, we treat people, not just their cancer. A cancer diagnosis is difficult. Our team of cancer care experts will help you find the best treatment options for you. We are a comprehensive cancer treatment center that gives you access to the most advanced therapies and technologies, while providing both you and your loved ones compassionate care, support, and resources to ensure your health and wellness during and after treatment."

During the past decade, Spokane Valley Cancer Center-Mayfair conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 16 clinical trials were completed, i.e. on average, 45.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spokane Valley Cancer Center-Mayfair" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Arcus Biosciences, Inc." with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spokane Valley Cancer Center-Mayfair" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Spokane Valley Cancer Center-Mayfair" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Colorectal Cancer" (5 trials), "Breast Cancer" (4 trials) and "Non-small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Spokane Valley Cancer Center-Mayfair" in a lesser frequency.

Most popular intervention types in "Spokane Valley Cancer Center-Mayfair" are "Drug" (42 trials), "Other" (20 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Docetaxel" (6 trials), "Nivolumab" (6 trials), "Pembrolizumab" (6 trials) and "Quality-of-Life Assessment" (5 trials). Other intervention names were less common.

The vast majority of trials in "Spokane Valley Cancer Center-Mayfair" are 41 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Spokane Valley Cancer Center-Mayfair". undefined are not yet recruiting, 10 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Spokane Valley Cancer Center-Mayfair, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Spokane Valley Cancer Center-Mayfair, 14 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Spokane Valley Cancer Center-Mayfair has several departments that took part in Clinical trials: "Medical Oncology Associates" - 49 trials, "Spokane Valley Cancer Center-Mission" - 17 trials